More data is being generated than can be analysed - but enough of it is being studied to spot patterns in behaviour and genes to speed up drug discovery and development.
Though the data scientists need to make sure they feed in the right data. For example, in a study designed to detect hip fractures, it turned out the AI was using the patient's age and particularly the imaging device model to make its prediction. This worked because portable scanners are only used then the patient is too immobile to get to a hospital - and this limitation turned out to be a bigger indicator than any details on the image itself.
Company providing artificial intelligence application for skincare.
Managing partner at Deep Knowledge Ventures
AMA with Sergey Young, Alex Zhavoronkov and Sourav Sinha
Artificial Intelligence for the impartial analysis of skin health & testing the efficiency of anti-aging products.
AI platform for professionals.
Combating aging and associated diseases. An Alphabet (Google) subsidiary.
AI to track the rate of ageing at the molecular, cellular, tissue, organ, system, physiological, and psychological levels
AI-powered biotechnology company.
Bioage licenses new drugs to treat ageing and age-related diseases
Lifespan.io (LEAF) - 28-Apr-2021
Raised $90M in series C funding - off to a great start initiating three clinical trialsRead more...
Insitro secures $400 million in series C funding
FierceBiotech - 15-Mar-2021
Giant leap towards developing transformative medicines powered by machine learningRead more...
Richard Ljuhar sheds light on AI-driven ImageBiopsy lab
Medical Expo - 10-Mar-2021
Highlights the diagnostic accuracy of musculoskeletal diseases using AI processed medical imagingRead more...